PROEHL GERALD T - 23 Nov 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
President, CEO and Chairman, Director, 10%+ Owner
Signature
/s/ Gerald T. Proehl
Issuer symbol
DRMA
Transactions as of
23 Nov 2021
Net transactions value
+$48,000
Form type
4
Filing time
26 Nov 2021, 12:30:47 UTC
Previous filing
17 Aug 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRMA Common Stock Purchase $48,000 +20,000 +51% $2.40 59,512 23 Nov 2021 Direct
holding DRMA Common Stock 17,857 23 Nov 2021 By Allison Taylor Proehl 2020 Irrevocable Trust F1
holding DRMA Common Stock 8,928 23 Nov 2021 By Meghan Proehl Wilder 2020 Irrevocable Trust F1
holding DRMA Common Stock 35,767 23 Nov 2021 By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020 F1
holding DRMA Common Stock 2,905,544 23 Nov 2021 By Proehl Investment Ventures LLC F1
holding DRMA Common Stock 152,857 23 Nov 2021 By Proehl Family Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.